Results indicated that deletion of Fgl2 from tumor-specific OT-I CD8+ T cells significantly increased both the frequency and cell count of FcγRIIB+ CD8+ OT-I in the draining lymph node (Fig. 4c–e). The gene discussed is FGL2; the disease is neoplasm.